In addition, given that the CONUT score is an index based on lymphocyte count, albumin level, and cholesterol level, each of which can be improved by improving the nutritional and immune status of patients, improvement in the CONUT score reflects improvement in nutritional and immune status, which can indirectly reduce the risk of non‐CRC‐related death. This evidence concerns the gene ALB and colorectal carcinoma.